View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Enphase Energy Inc: 1 director

A director at Enphase Energy Inc sold 5,000 shares at 118.824USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

Appfolio Inc: 1 director

A director at Appfolio Inc sold 8,210 shares at 249.756USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

Epsilon Announces 2024 AGM Results

Epsilon Announces 2024 AGM Results HOUSTON, May 16, 2024 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) is pleased to announce that all the nominees listed in its Proxy Statement, Schedule 14A dated on April 11, 2024 were elected as directors of Epsilon, until the next annual meeting of shareholders. The detailed results of the vote at the annual shareholders meeting held on Wednesday, May 15, 2024 are set out below. At the meeting, the number of directors was set at six and each of the following six nominees proposed by management was elected as a di...

 PRESS RELEASE

Enphase Energy Releases 2023 Environmental, Social, and Governance Rep...

Enphase Energy Releases 2023 Environmental, Social, and Governance Report FREMONT, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today the release of its 2023 Environmental, Social, and Governance (ESG) report, which provides an update on Enphase's ESG policies, initiatives, and performance. “We are pleased to share our progress in advancing a sustainable future for all,” said Lisan Hung, senior vice president, general counsel, and corporate secretar...

Martin Fan ... (+4)
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina
 PRESS RELEASE

Clene to Present at Upcoming May Conferences

Clene to Present at Upcoming May Conferences SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis and multiple sclerosis, today announced that it will participate in the following investor conferences in May. Mizuho Neuroscience Summit 2024Dates: May 20-21, 2024Location: ...

Martin Fan ... (+4)
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Sam Ravina

Landmark Bancorp Inc: 1 director

A director at Landmark Bancorp Inc bought 1,050 shares at 18.961USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

 PRESS RELEASE

Vera Therapeutics Provides Business Update and Reports First Quarter 2...

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatmentTopline 96-week data from ORIGIN 2 trial expected in Q4 2024Pivotal Phase 3 ORIGIN 3 trial estimated to complete enrollment for primary endpoint in Q3 2024; topline data expected in 1H 2025Completed $287.5 million financing, further strengthening the Company’s balance sheet BRISBANE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Vera Thera...

 PRESS RELEASE

Whole Earth Brands Reports First Quarter 2024 Results

Whole Earth Brands Reports First Quarter 2024 Results CHICAGO, May 09, 2024 (GLOBE NEWSWIRE) -- Whole Earth Brands, Inc. (the “Company” or “we” or “our”) (Nasdaq: FREE), a global food company enabling healthier lifestyles through premium plant-based sweeteners, flavor enhancers and other foods, today announced its financial results for its first quarter ended March 31, 2024. First Quarter Highlights Consolidated revenue of $129.5 million, a decrease of 2.2% on a reported basis and 2.3% on a constant currency basis compared to the prior year period.Branded CPG revenue decreased 3.5% ...

Matthew McCartney ... (+3)
  • Matthew McCartney
  • Nathan Friedman
  • Seth Basham
 PRESS RELEASE

Epsilon Reports First Quarter 2024 Results

Epsilon Reports First Quarter 2024 Results  HOUSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported first quarter 2024 financial and operating results. Epsilon’s highlights for first quarter 2024 include: Net revenue interest (NRI) total production of 2.0 Bcfe (21.8 MMcfe per day, 16% liquids) for the quarter ended March 31, 2024, a decrease of 11% compared to the prior quarter. 1.7 Bcf net revenue interest (NRI) natural gas production, a decrease of 16% compared to the prior quarter 44% of the decrease (0.2 Bcf) is att...

Southwest Gas Corporation: Update following ratings affirmation

Our credit view of this issuer reflects its strong customer growth, offset by its temporarily weak credit metrics as a result of debt funded natural gas costs.

 PRESS RELEASE

Clene Reports First Quarter 2024 Financial Results and Recent Operatin...

Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights Data from long-term extension of Phase 2 VISIONARY-MS clinical trial of CNM-Au8® demonstrated significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p

 PRESS RELEASE

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 1, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 15,000 shares of Class A common stock and restricted stock units (RSUs) for 7,500 shares of Class A common stock to three new employees under Vera’s 2024 Inducement Plan (the Inducement Plan). Vera also announced that on May 6, 2024, the Compensation ...

 PRESS RELEASE

Enphase Energy Expands IQ8 Commercial Microinverter Deployments in Nor...

Enphase Energy Expands IQ8 Commercial Microinverter Deployments in North America FREMONT, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that installers of Enphase® products across North America have seen growing deployments of IQ8™ Commercial Microinverters. A recent Wood Mackenzie report estimated that only 5.1% of viable U.S. commercial properties had solar installations by the end of 2023. IQ8 Commercial Microinverters , enabling solar insta...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch